113 related articles for article (PubMed ID: 20599586)
1. A central neuropathic pain model by DSP-4 induced lesion of noradrenergic neurons: preliminary report.
Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
Neurosci Lett; 2010 Sep; 481(2):102-4. PubMed ID: 20599586
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of neurotropin in a rat model of central neuropathic pain: DSP-4 induced noradrenergic lesion.
Kudo T; Kushikata T; Kudo M; Kudo T; Hirota K
Neurosci Lett; 2011 Sep; 503(1):20-2. PubMed ID: 21843596
[TBL] [Abstract][Full Text] [Related]
3. Central noradrenergic activity affects analgesic effect of Neuropeptide S.
Jinushi K; Kushikata T; Kudo T; Calo G; Guerrini R; Hirota K
J Anesth; 2018 Feb; 32(1):48-53. PubMed ID: 29128909
[TBL] [Abstract][Full Text] [Related]
4. Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain.
Fritschy JM; Grzanna R
J Comp Neurol; 1992 Jul; 321(3):421-41. PubMed ID: 1506478
[TBL] [Abstract][Full Text] [Related]
5. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala.
Radwanska K; Nikolaev E; Kaczmarek L
Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329
[TBL] [Abstract][Full Text] [Related]
6. Selective lesion of the developing central noradrenergic system: short- and long-term effects and reinnervation by noradrenergic-rich tissue grafts.
Coradazzi M; Gulino R; Garozzo S; Leanza G
J Neurochem; 2010 Aug; 114(3):761-71. PubMed ID: 20477936
[TBL] [Abstract][Full Text] [Related]
7. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
Srinivasan J; Schmidt WJ
J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
[TBL] [Abstract][Full Text] [Related]
8. Influence of peripheral nerve injury on response properties of locus coeruleus neurons and coeruleospinal antinociception in the rat.
Viisanen H; Pertovaara A
Neuroscience; 2007 Jun; 146(4):1785-94. PubMed ID: 17445989
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
Fritschy JM; Grzanna R
Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
11. Spinal and pontine alpha2-adrenoceptors have opposite effects on pain-related behavior in the neuropathic rat.
Wei H; Pertovaara A
Eur J Pharmacol; 2006 Dec; 551(1-3):41-9. PubMed ID: 17027962
[TBL] [Abstract][Full Text] [Related]
12. Repetitive treatment with diluted bee venom reduces neuropathic pain via potentiation of locus coeruleus noradrenergic neuronal activity and modulation of spinal NR1 phosphorylation in rats.
Kang SY; Roh DH; Yoon SY; Moon JY; Kim HW; Lee HJ; Beitz AJ; Lee JH
J Pain; 2012 Feb; 13(2):155-66. PubMed ID: 22217441
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn.
Fritschy JM; Grzanna R
J Comp Neurol; 1990 Jan; 291(4):553-82. PubMed ID: 2329191
[TBL] [Abstract][Full Text] [Related]
15. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
Fritschy JM; Grzanna R
Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
[TBL] [Abstract][Full Text] [Related]
16. Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy.
Giorgi FS; Mauceli G; Blandini F; Ruggieri S; Paparelli A; Murri L; Fornai F
Epilepsia; 2006; 47 Suppl 5():21-5. PubMed ID: 17239101
[TBL] [Abstract][Full Text] [Related]
17. Selective Lifelong Destruction of Brain Monoaminergic Nerves Through Perinatal DSP-4 Treatment.
Nowak P
Curr Top Behav Neurosci; 2016; 29():51-71. PubMed ID: 26427851
[TBL] [Abstract][Full Text] [Related]
18. Chemical destruction of brain noradrenergic neurons affects splenic cytokine production.
Engler H; Doenlen R; Riether C; Engler A; Besedovsky HO; Del Rey A; Pacheco-López G; Schedlowski M
J Neuroimmunol; 2010 Feb; 219(1-2):75-80. PubMed ID: 20031236
[TBL] [Abstract][Full Text] [Related]
19. Role of coerulean noradrenergic neurones in general anaesthesia in rats.
Kushikata T; Yoshida H; Kudo M; Kudo T; Kudo T; Hirota K
Br J Anaesth; 2011 Dec; 107(6):924-9. PubMed ID: 21965049
[TBL] [Abstract][Full Text] [Related]
20. Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat.
Lee SE; Kim JH
Neurosci Res; 2007 Jul; 58(3):245-9. PubMed ID: 17428562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
